Randomized Study of Obicetrapib as an Adjunct to Statin Therapy

Clinical trial NCT04753606 · COMPLETED

Trial details

NCT number: NCT04753606
Sponsor: NewAmsterdam Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemias High Cholesterol Hypercholesterolemia

Start date: 2021-02-18
Primary completion: 2021-05-24
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.